Bioadaptives, Inc. SEC filings BDPT
Bioadaptives, Inc. has 176 filings in SEC EDGAR's recent list, going back to May 3, 2013. Its latest annual report, Form 10-K, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-Q | Form nt 10-q | Aug 14, 2026 | Jun 30, 2026 |
| NT 10-K | Form nt 10-k | Mar 31, 2026 | Dec 31, 2025 |
| NT 10-K | Form nt 10-k | Mar 31, 2025 | Dec 31, 2024 |
| SEC STAFF ACTION | Filing | Feb 24, 2025 | — |
| NT 10-Q | Filing | Nov 14, 2024 | Sep 30, 2024 |
| NT 10-Q | Filing | Aug 15, 2024 | Jun 30, 2024 |
| NT 10-Q | Filing | May 15, 2024 | Mar 31, 2024 |
| NT 10-K | Filing | Apr 1, 2024 | Dec 31, 2023 |
| 1-A | Filing | Oct 11, 2023 | — |
| 1-Z | Filing | Aug 24, 2023 | — |
| QUALIF | Filing | Nov 17, 2022 | — |
| CORRESP | Letter to the SEC | Nov 15, 2022 | — |
| 1-A POS | Filing | Nov 8, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 31, 2022 | — |
| CORRESP | Letter to the SEC | Oct 28, 2022 | — |
| 1-A POS | Filing | Oct 28, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 20, 2022 | — |
| 1-A POS | Filing | Oct 7, 2022 | — |
| 253G1 | Form 253g1 | May 16, 2022 | — |
| QUALIF | Filing | May 11, 2022 | — |
| CORRESP | Letter to the SEC | May 9, 2022 | — |
| 1-A/A | Filing | May 3, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2022 | — |
| 1-A/A | Filing | Mar 18, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 16, 2022 | — |
| 1-A | Filing | Mar 4, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 1, 2019 | — |
| 10-12G/A | Filing | Jul 23, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2019 | — |
| 10-12G/A | Filing | Jun 27, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2019 | — |
| 10-12G | Filing | May 10, 2019 | — |
| 15-15D | Filing | Mar 31, 2017 | — |
| NT 10-Q | Filing | Nov 15, 2016 | Sep 30, 2016 |
| NT 10-Q | Form 12b-25 | Aug 16, 2016 | Jun 30, 2016 |
| NT 10-Q | Form 12b-25 | May 17, 2016 | Mar 31, 2016 |
| NT 10-K | Form 12b-25 | Mar 31, 2016 | Dec 31, 2015 |
| NT 10-Q | Form 12b-25 | Nov 16, 2015 | Sep 30, 2015 |
| NT 10-Q | Filing | Aug 14, 2015 | Jun 30, 2015 |
| NT 10-Q | Filing | May 18, 2015 | Mar 31, 2015 |
| NT 10-K | Filing | Mar 31, 2015 | Dec 31, 2014 |
| NT 10-Q | Filing | May 15, 2014 | Mar 31, 2014 |
| NT 10-K | Filing | Mar 28, 2014 | Dec 31, 2013 |
| EFFECT | Filing | Jan 10, 2014 | — |
| D | Filing | Oct 8, 2013 | — |
| UPLOAD | Letter from the SEC | Aug 19, 2013 | — |
| CORRESP | Letter to the SEC | Aug 6, 2013 | — |
| UPLOAD | Letter from the SEC | Jul 23, 2013 | — |
| UPLOAD | Letter from the SEC | Jun 11, 2013 | — |
| UPLOAD | Letter from the SEC | May 31, 2013 | — |
| CORRESP | Letter to the SEC | May 31, 2013 | — |
| 10-12G/A | Form 10 | May 31, 2013 | — |
| 10-12G | Form 10 | May 3, 2013 | — |
Showing 53 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BDPT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1575142
- Former names
- APEX 8 Inc. (until Aug 19, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.